Global Dextrose Injection Market to Surpass US$ 14,056.6 Million by 2027, Says Coherent Market Insights (CMI)
October 12, 2020SEATTLE–(BUSINESS WIRE)–#DextroseInjection–According to Coherent Market Insights, the global dextrose injection market is estimated to be valued at US$ 9,512.7 million in 2020 and is expected to exhibit a CAGR of 5.7% during the forecast period (2020-2027).
Key Trends and Analysis:
Key trends in the dextrose injection market are rising incidence of patients suffering from hypoglycemic conditions, increasing launches and approval of novel products, and robust pipeline of products.
According to a survey conducted by the Centers for Disease Control and Prevention (CDC), in 2016, more than 1.5 million people in the U.S. suffered from hypoglycemia.
Key players operating in the market are focusing on novel product launches and approvals in order to expand their product portfolio and increase presence in the global market.
For instance, in July 2020, Hikma Pharmaceuticals PLC (Hikma), a multinational pharmaceutical company, launched Dacarbazine for Injection with dextrose solution for the treatment of metastatic malignant melanoma. The reconstituted solution may be further diluted with 5% dextrose injection or sodium chloride injection and administered as an intravenous infusion.
For instance, in 2017, Clindamycin in dextrose injection (D5W) made by Water Street Healthcare Partners, a private equity firm, which focuses extensively on building market leading companies in healthcare and Celerity Pharmaceuticals LLC, which provides drug development services, was approved by the U.S. Food and Drug Administration. (Read more…)
Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/1835
For instance, in February 2017, Tri service general hospital, a medical center in Neihu District, Taipei, Taiwan, completed its 5% Dextrose injection phase 1 clinical trials. 5% dextrose injection is used to treat ulnar neuropathy (peripheral entrapment neuropathy) at elbow. Since 2017, Tri service general hospital reported to have 10% dextrose injection in phase 2 clinical trials. 10% dextrose injection is used to treat Carpal tunnel syndrome. Carpal tunnel syndrome causes pain, numbness, and tingling in the hands.
Key Market Takeaways:
The global dextrose injection market is expected to expand at a CAGR of 5.7% during the forecast period, owing to increasing approval of novel drugs. For instance, in February 2016, Aurobindo Pharmaceuticals Ltd. received the U.S. FDA approval for Levofloxacin Injection in dextrose injection, which is indicated for the treatment of bacterial infection in adults.
Among product type, 5% dextrose injection segment is estimated to hold a dominant position in the global dextrose injection market in 2020, owing to its less side effects on body as compared to other dextrose injection and it is mostly used for the treatment of low blood sugar (hypoglycemia), insulin shock or dehydration (fluid loss).
Among application, first-aid treatment segment is estimated to hold a dominant position in the global dextrose injection market in 2020 due to its application in first-aid treatment as a nutrition support.
North America is estimated to hold largest market share in the global dextrose injection market in 2020, owing to increasing number of patient population and presence of big manufacturers such as Pfizer, Baxter International Inc., and others in the region.
Competitive Landscape:
Pfizer Inc., Amphastar Pharmaceuticals Inc., Shangai Haixin group Co. Ltd., Seqirus GmbH, Baxter International Inc., Shandong Qidu Pharmaceutical, Sanctus drugs and pharmaceuticals Pvt., Hospira Inc., B Braun Medical Ltd., Aurobindo Pharmaceuticals Ltd., and SteriMAx Inc.
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/1835
Market Segmentation:
-
Global Dextrose Injection Market, By Product Type:
- 5% Dextrose Injection
- 10% Dextrose Injection
- 50% Dextrose Injection
- 70% Dextrose Injection
- Others
-
Global Dextrose Injection Market, By Application:
- First-aid Treatment
- Sports
- Trophotherapy
- Others
-
Global Dextrose Injection Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
-
Global Dextrose Injection Market, By Region:
-
North America
- U.S.
- Canada
-
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
-
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
-
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
-
Middle East
- GCC
- Israel
- Rest of Middle East
-
Africa
- South Africa
- Central Africa
- North Africa
-
North America
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide.
Contacts
Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: [email protected]
Website: https://www.coherentmarketinsights.com
Follow Us: LinkedIn | Twitter
Global Dextrose Injection Market to Surpass US$ 14,056.6 Million by 2027, Says Coherent Market Insights (CMI)
October 12, 2020SEATTLE–(BUSINESS WIRE)–#DextroseInjection–According to Coherent Market Insights, the global dextrose injection market is estimated to be valued at US$ 9,512.7 million in 2020 and is expected to exhibit a CAGR of 5.7% during the forecast period (2020-2027).
Key Trends and Analysis:
Key trends in the dextrose injection market are rising incidence of patients suffering from hypoglycemic conditions, increasing launches and approval of novel products, and robust pipeline of products.
According to a survey conducted by the Centers for Disease Control and Prevention (CDC), in 2016, more than 1.5 million people in the U.S. suffered from hypoglycemia.
Key players operating in the market are focusing on novel product launches and approvals in order to expand their product portfolio and increase presence in the global market.
For instance, in July 2020, Hikma Pharmaceuticals PLC (Hikma), a multinational pharmaceutical company, launched Dacarbazine for Injection with dextrose solution for the treatment of metastatic malignant melanoma. The reconstituted solution may be further diluted with 5% dextrose injection or sodium chloride injection and administered as an intravenous infusion.
For instance, in 2017, Clindamycin in dextrose injection (D5W) made by Water Street Healthcare Partners, a private equity firm, which focuses extensively on building market leading companies in healthcare and Celerity Pharmaceuticals LLC, which provides drug development services, was approved by the U.S. Food and Drug Administration. (Read more…)
Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/1835
For instance, in February 2017, Tri service general hospital, a medical center in Neihu District, Taipei, Taiwan, completed its 5% Dextrose injection phase 1 clinical trials. 5% dextrose injection is used to treat ulnar neuropathy (peripheral entrapment neuropathy) at elbow. Since 2017, Tri service general hospital reported to have 10% dextrose injection in phase 2 clinical trials. 10% dextrose injection is used to treat Carpal tunnel syndrome. Carpal tunnel syndrome causes pain, numbness, and tingling in the hands.
Key Market Takeaways:
The global dextrose injection market is expected to expand at a CAGR of 5.7% during the forecast period, owing to increasing approval of novel drugs. For instance, in February 2016, Aurobindo Pharmaceuticals Ltd. received the U.S. FDA approval for Levofloxacin Injection in dextrose injection, which is indicated for the treatment of bacterial infection in adults.
Among product type, 5% dextrose injection segment is estimated to hold a dominant position in the global dextrose injection market in 2020, owing to its less side effects on body as compared to other dextrose injection and it is mostly used for the treatment of low blood sugar (hypoglycemia), insulin shock or dehydration (fluid loss).
Among application, first-aid treatment segment is estimated to hold a dominant position in the global dextrose injection market in 2020 due to its application in first-aid treatment as a nutrition support.
North America is estimated to hold largest market share in the global dextrose injection market in 2020, owing to increasing number of patient population and presence of big manufacturers such as Pfizer, Baxter International Inc., and others in the region.
Competitive Landscape:
Pfizer Inc., Amphastar Pharmaceuticals Inc., Shangai Haixin group Co. Ltd., Seqirus GmbH, Baxter International Inc., Shandong Qidu Pharmaceutical, Sanctus drugs and pharmaceuticals Pvt., Hospira Inc., B Braun Medical Ltd., Aurobindo Pharmaceuticals Ltd., and SteriMAx Inc.
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/1835
Market Segmentation:
-
Global Dextrose Injection Market, By Product Type:
- 5% Dextrose Injection
- 10% Dextrose Injection
- 50% Dextrose Injection
- 70% Dextrose Injection
- Others
-
Global Dextrose Injection Market, By Application:
- First-aid Treatment
- Sports
- Trophotherapy
- Others
-
Global Dextrose Injection Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
-
Global Dextrose Injection Market, By Region:
-
North America
- U.S.
- Canada
-
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
-
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
-
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
-
Middle East
- GCC
- Israel
- Rest of Middle East
-
Africa
- South Africa
- Central Africa
- North Africa
-
North America
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide.
Contacts
Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: [email protected]
Website: https://www.coherentmarketinsights.com
Follow Us: LinkedIn | Twitter